Pinnacle Financial Partners’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $37.1K | Hold |
1,000
| – | – | ﹤0.01% | 493 |
|
|
2024
Q4 | $48.5K | Hold |
1,000
| – | – | ﹤0.01% | 481 |
|
|
2024
Q3 | $48.5K | Hold |
1,000
| – | – | ﹤0.01% | 480 |
|
|
2024
Q2 | $43.9K | Hold |
1,000
| – | – | ﹤0.01% | 484 |
|
|
2024
Q1 | $43.9K | Hold |
1,000
| – | – | ﹤0.01% | 479 |
|
|
2023
Q4 | $61.9K | Hold |
1,000
| – | – | ﹤0.01% | 451 |
|
|
2023
Q3 | $46K | Hold |
1,000
| – | – | ﹤0.01% | 435 |
|
|
2023
Q2 | $57.5K | Hold |
1,000
| – | – | ﹤0.01% | 434 |
|
|
2023
Q1 | $37.5K | Hold |
1,000
| – | – | ﹤0.01% | 446 |
|
|
2022
Q4 | $28K | Hold |
1,000
| – | – | ﹤0.01% | 447 |
|
|
2022
Q3 | $28K | Hold |
1,000
| – | – | ﹤0.01% | 437 |
|
|
2022
Q2 | $35K | Hold |
1,000
| – | – | ﹤0.01% | 387 |
|
|
2022
Q1 | $36K | Hold |
1,000
| – | – | ﹤0.01% | 399 |
|
|
2021
Q4 | $23K | Hold |
1,000
| – | – | ﹤0.01% | 437 |
|
|
2021
Q3 | $19K | Hold |
1,000
| – | – | ﹤0.01% | 438 |
|
|
2021
Q2 | $20K | Hold |
1,000
| – | – | ﹤0.01% | 440 |
|
|
2021
Q1 | $20K | Hold |
1,000
| – | – | ﹤0.01% | 391 |
|
|
2020
Q4 | $19K | Hold |
1,000
| – | – | ﹤0.01% | 393 |
|
|
2020
Q3 | $19K | Hold |
1,000
| – | – | ﹤0.01% | 385 |
|
|
2020
Q2 | $22K | Hold |
1,000
| – | – | ﹤0.01% | 370 |
|
|
2020
Q1 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 377 |
|
|
2019
Q4 | $19K | Buy |
+1,000
| New | +$19K | ﹤0.01% | 415 |
|
|
2019
Q2 | – | Sell |
-1,000
| Closed | -$20K | – | 351 |
|
|
2019
Q1 | $20K | Buy |
+1,000
| New | +$20K | ﹤0.01% | 383 |
|
|
2018
Q4 | – | Sell |
-1,000
| Closed | -$19K | – | 320 |
|
|
2018
Q3 | $19K | Hold |
1,000
| – | – | ﹤0.01% | 394 |
|
|
2018
Q2 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 371 |
|
|
2018
Q1 | $19K | Buy |
+1,000
| New | +$19K | ﹤0.01% | 368 |
|